Literature DB >> 1310528

Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection.

P F Bray1, K W Culp, D E McFarlin, H S Panitch, R D Torkelson, J P Schlight.   

Abstract

This report describes five patients who, following a neurologically complicated primary Epstein-Barr virus infection, developed progressive or relapsing neurologic deficits. The sequelae in four patients followed 4 to 12 years led to the diagnosis of multiple sclerosis (MS). The fifth patient presented with acute disseminated sclerosis and exhibits diffuse neurologic deficits that have persisted for 2 years. We suggest that the diagnosis of an unexplained acute neurologic or psychiatric syndrome should raise the question of a primary EBV etiology. A precisely timed serologic and hematologic study of the blood is imperative to capture the essential evidence. The data presented represent a clinical association between a neurologically complicated primary EBV infection and both chronic and acute demyelinating disease. The evidence does not justify a conclusion that EBV virus causes MS.

Entities:  

Mesh:

Year:  1992        PMID: 1310528     DOI: 10.1212/wnl.42.2.278

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Multiple sclerosis and Epstein-Barr virus.

Authors:  Ruth Ann Marrie; Christina Wolfson
Journal:  Can J Infect Dis       Date:  2002-03

2.  Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation.

Authors:  D A Hilton; S Love; A Fletcher; J H Pringle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

3.  Acute fatal necrotizing hemorrhagic encephalitis caused by Epstein-Barr virus in a young adult immunocompetent man.

Authors:  Daniela Francisci; Alessandra Sensini; Daniela Fratini; Maria Vittoria Moretti; Maria Laura Luchetta; Antonino Di Caro; Giuliano Stagni; Franco Baldelli
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

4.  Epstein-Barr virus infection of human astrocyte cell lines.

Authors:  A Menet; C Speth; C Larcher; W M Prodinger; M G Schwendinger; P Chan; M Jäger; F Schwarzmann; H Recheis; M Fontaine; M P Dierich
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis.

Authors:  Fumitaka Sato; Nicholas E Martinez; Maira Shahid; John W Rose; Noel G Carlson; Ikuo Tsunoda
Journal:  Am J Pathol       Date:  2013-10-01       Impact factor: 4.307

6.  Epstein-Barr virus encephalitis and encephalomyelitis: MR findings.

Authors:  W J Shian; C S Chi
Journal:  Pediatr Radiol       Date:  1996-09

Review 7.  Herpesviruses--a rationale for antiviral treatment in multiple sclerosis.

Authors:  T Bergström
Journal:  Antiviral Res       Date:  1999-02       Impact factor: 5.970

8.  An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue.

Authors:  Margaret L Opsahl; Peter G E Kennedy
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

Review 9.  Synaptic Plasticity and Neurological Disorders in Neurotropic Viral Infections.

Authors:  Venkata Subba Rao Atluri; Melissa Hidalgo; Thangavel Samikkannu; Kesava Rao Venkata Kurapati; Madhavan Nair
Journal:  Neural Plast       Date:  2015-11-16       Impact factor: 3.599

10.  Evidence for multiple sclerosis as an infectious disease.

Authors:  S D Cook; C Rohowsky-Kochan; S Bansil; P C Dowling
Journal:  Acta Neurol Scand Suppl       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.